서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 90

Issue DateTitle / Author(s) / CitationFileAltmetrics
2001-04
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study
DOI
2003-08
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial
DOI
2003-12
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
DOI
2004-11
Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60
link
2005-09
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization
DOI
2006-07
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
DOI
2006-08
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
link
2007
Microenvironment effects on promoting upregulation of matrix metalloproteinases in Bcl-2-overexpressing renal cell carcinoma as a response to doxorubicin treatment inducing the production of metastasis
link
2007
Pneumatosis intestinalis with pneumoperitoneum mimicking intestinal perforation in a patient with myelodysplastic syndrome after hematopoietic stem cell transplantation

Keam, Bhumsuk; Lee, Jeong-Hoon; Oh, Myoung-Don; Kim, Inho; Yoon, Sung-Soo; Kim, Byoung Kook; Park, Seonyang

The Korean Journal of Internal Medicine 22(1):40-44.

link
2007
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
view fileDOI
2007
Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
link
2007
Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib
link
2007-04
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
link
2007-04
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning
view filelink
2007-04
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning
view filelink
2007-05
Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation
link
2007-05
Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation
link
2007-05
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
link
2007-05
Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
link
2007-06
Microenvironment effects on promoting upregulation of matrix metalloproteinases in Bcl-2-overexpressing renal cell carcinoma as a response to doxorubicin treatment inducing the production of metastasis
link
2008-06
Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea
link
2009
Clinical predictors of recurrent venous thromboembolism A single institute experience in Korea
DOI
2009-04
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells
DOI
2009-08
Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction
DOI
2009-09
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement
DOI
2009-11
p15INK4b Methylation is Related to Blast Percentage, Thrombocytopenia, the Number of Lineages Involved in Cytopenia and Survival in Myelodysplastic Syndrome at the Time of Diagnosis: a Pyrosequencing Study
2009-11
Clinical Efficacy and Tolerability of Granulocyte Transfusions for the Treatment of Febrile Neutropenia in the Patients with Hematologic Malignancies
2009-11
Efficacy of ICT with Deferasirox in Transfusional Iron Overloaded Patients with MDS or AA
2009-11
Hypoplastic Myelodysplastic Syndrome (h-MDS) Is a Distinctive Clinical Entity with Poorer Prognosis and Frequent Karyotypic and FISH Abnormalities Compared to Aplastic Anemia (AA)
2009-11
Bortezomib Resistant Multiple Myeloma Cells Are Tumor Initiating Cells That Have a Stem Cell-Like Genetic Signature.
2009-11
Myelomatous Pleural Effusion of Multiple Myeloma: Characteristics and Outcome
2009-11
Prognosis of Secondary Acute Myeloid Leukemia Is Affected by the Type of the Preceding Hematologic Disorders and the Presence of Trisomy 8
2009-11
Immunoglobulin D Multiple Myeloma: Clinical Presentation, Response to Therapy and Prognostic Factors in 75 Patients; An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).
2009-11
Treatment Outcome of Steroid-Refractory Chronic Graft-Versus-Host Disease with Weekly Rituximab Followed by Maintenance Rituximab: a KSBMT Multicenter Phase II Study.
2009-11
Patients with Hematologic Malignancies May Be at Higher Risk of Hepatitis B Reactivation in Spite of Lamivudine Prophylaxis
2010-01
Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients
DOI
2010-01
Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60
DOI
2010-01
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
DOI
2010-05
Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
view fileDOI
2010-08
Patient HSP70-hom TG haplotype is associated with decreased transplant-related mortality and improved survival after sibling HLA-matched hematopoietic stem cell transplantation
DOI
2010-08
Molecular characterization and prognostic significance of FLT3 in CML progression
DOI
2010-09
Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model
DOI
2010-11
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study
view fileDOI
2010-11
Increased Copy Number of Interleukin-6 Receptor Gene Is Associated with Adverse Survival In Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation
2010-11
Allogeneic Stem Cell Transplantation (alloSCT) and Donor Lymphocyte Infusion (DLI) In Patients with Non-Hodgkin Lymphoma (NHL) Who Experienced Relapse or Progression After Autologous Stem Cell Transplantation (autoSCT): Retrospective Analysis From the Korean Society of Blood and Marrow Transplantation.
2010-11
Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies
2010-11
Clonal Cells Detected by Conventional Cytogenetic Analysis Correlates with Bone Marrow Blast Percentage and Progression Free Survival Into Acute Leukemia In Myelodysplastic Syndromes
2010-11
TNF alpha Mediated IL-6 Secretion Was Regulated by JAK/STAT Pathway but Not by MEK Phosphorylation and AKT phopshorylaton In U266 Multiple Myeloma Cells
2010-12
Prognosis of Secondary Acute Myeloid Leukemia is Affected by the Type of the Preceding Hematologic Disorders and the Presence of Trisomy 8
DOI
2010-12
Korean Patients with Superwarfarin Intoxication and Their Outcome
view fileDOI
2011-03
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: The 10-year experience of a single center
DOI
2011-08
Clinical dissection of multicentric Castleman disease
DOI
2013-10
Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement
view filelink
2016-10
MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis
DOI
2018-09
Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation
view fileDOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
DOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
view fileDOI
2019-08
ERK-dependent IL-6 positive feedback loop mediates resistance against a combined treatment using danusertib and BKM120 in Burkitt lymphoma cell lines
DOI
2019-10
Body Cavity- Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma
DOI
2020-03
Limited Positive Predictive Value of β-D-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
DOI
1 2